MFAT for Auto Injury Recovery: A Transformative Approach
Table of Contents
Car accidents can damage more than one part of the body at the same time. A collision may injure cartilage, tendons, ligaments, muscles, joints, and the spine. Even after the first pain improves, damaged tissues may continue to cause inflammation, weakness, poor movement, stiffness, or loss of function.
Micro-Fragmented Adipose Tissue (MFAT) is an advanced regenerative treatment that uses a small amount of a patient’s own fat tissue. The tissue is gently collected and mechanically processed without harsh enzymes or chemical digestion. The processed tissue contains a natural mixture of structural tissue, signaling cells, growth factors, and other substances that may support a healthier healing environment.
For selected patients, MFAT may be combined with scientific chiropractic care and rehabilitation. MFAT focuses on the biological environment of injured tissue, while chiropractic rehabilitation focuses on joint motion, spinal mechanics, strength, balance, and movement. At Injury Medical Clinic PA in El Paso, Texas, this approach can also include internal medicine oversight, functional medicine, personal injury care, and progressive rehabilitation.
This article explains what MFAT is, how it may support musculoskeletal recovery, what current research shows, and how regenerative medicine can fit into an integrative chiropractic treatment plan after an auto accident.
Micro-Fragmented Adipose Tissue, often shortened to MFAT or mFAT, is a regenerative treatment made from the patient’s own adipose, or fat, tissue.
The word autologous is often used to describe MFAT. This simply means the tissue comes from the same person who receives it.
During an MFAT procedure, a healthcare professional collects a small amount of fat, often from the abdomen or another suitable area. The tissue is then washed and mechanically processed into smaller fragments.
Unlike some cell-processing methods, MFAT does not require enzymatic digestion or laboratory cell expansion.
Research suggests that mechanical processing can preserve important parts of the tissue’s natural structure, including the extracellular matrix and cells found around small blood vessels (Fu & Wang, 2025; Yuan et al., 2026).
MFAT may contain:
MFAT is more complex than a simple “stem cell injection.” It contains many different tissue components working together.
This natural combination is one reason researchers are studying MFAT for orthopedic and musculoskeletal conditions.
MFAT does not work like a medication that simply blocks pain.
Researchers believe much of its effect comes from biological signaling.
Cells and other components inside adipose tissue can release substances that communicate with nearby cells. Scientists call this paracrine signaling.
These signals may influence:
MFAT also keeps much of the natural extracellular matrix surrounding the cells. Think of this matrix as a tiny biological framework that provides structure and helps cells communicate with their surroundings.
According to Yuan et al. (2026), this combination may allow MFAT to act as both a biological signaling environment and a natural tissue scaffold.
However, MFAT should not be described as a treatment that is proven to completely regrow cartilage, ligaments, or tendons.
The science is promising, but research is still developing.
Car accidents create forces that the human body is not always prepared to handle.
During a crash, the body can suddenly twist, bend, compress, or stretch. During the same event, several areas can sustain injuries.
For example, a patient may experience:
Some injuries can also change the way the entire body moves.
Imagine a patient injuring the right knee in an automobile accident. Because the knee hurts, the patient begins putting more weight on the left leg.
Over time, that compensation may change the movement of the:
The original knee injury is biological, but the altered walking pattern creates a biomechanical problem.
This is where an integrative approach becomes important.
One central idea behind integrative regenerative care is that damaged tissue and abnormal movement should not always be treated as separate problems.
An injection may address the injured tissue.
Rehabilitation addresses how the patient uses that tissue.
The basic concept can be explained this way:
MFAT may support the biological environment of an injured area, while chiropractic rehabilitation works on the mechanical environment around it.
Scientific chiropractic rehabilitation may address:
This approach is especially useful when an injury has affected more than one part of the movement system.
It should also be clear that direct clinical trials proving that MFAT plus chiropractic care is superior to MFAT alone are currently limited.
Combining the two should therefore be understood as a coordinated clinical strategy based on the different roles of regenerative medicine and rehabilitation—not as a guaranteed treatment formula.
MFAT is not normally the first treatment used after every automobile accident.
Many musculoskeletal injuries improve with conservative treatment.
Early care may include:
MFAT may be considered when a patient has a more difficult or persistent injury.
Examples may include selected cases involving:
The decision should depend on the diagnosis, physical examination, imaging findings, overall health, and treatment history.
The strongest clinical evidence for MFAT currently involves knee osteoarthritis.
This is an important distinction.
Although MFAT is being studied for different orthopedic conditions, the scientific evidence should not be stretched beyond what current research actually shows.
In a randomized clinical trial, Baria et al. (2024) compared MFAT with platelet-rich plasma, or PRP, for knee osteoarthritis. Both groups improved in pain and function. MFAT was not clearly superior to PRP.
Another randomized study found that patients receiving MFAT for symptomatic knee osteoarthritis had better pain and function outcomes over one year than patients receiving a saline control injection (Richter et al., 2025).
Research reviews also suggest that MFAT has biological properties that could support musculoskeletal healing, including inflammation-modulating and tissue-signaling effects (Fu & Wang, 2025; Yuan et al., 2026).
However, systematic reviews have also warned that the quality and size of the clinical evidence remain limited. MFAT has not been shown to be universally better than other orthobiologic treatments (Hohmann et al., 2025).
For patients with auto injuries, this means MFAT should be considered based on the specific damaged tissue, not simply because a car accident occurred.
A regenerative procedure is only one part of recovery.
Once an injured area is treated, the patient must still learn to move safely and efficiently.
This is where chiropractic rehabilitation can play an important role.
The first goal is understanding what was damaged.
Evaluation may involve:
A clear diagnosis helps determine whether conservative treatment, regenerative care, specialist referral, or another treatment is appropriate.
Before or after a regenerative procedure, the rehabilitation team may look for movements that repeatedly stress the injured structure.
Care may address:
If an injury remains painful or slow to recover despite appropriate care, the medical team may determine whether MFAT or another regenerative option is appropriate.
Not every patient needs regenerative treatment.
Immediately after an MFAT procedure, patients must follow the instructions of the clinician who performed the treatment.
Aggressive activity may need to be temporarily reduced.
The goal is to avoid unnecessary stress while the area begins responding to treatment.
As the patient progresses, rehabilitation may include:
Later rehabilitation may become more challenging.
The patient may work toward:
The goal is not simply to reduce pain.
The larger goal is to restore function, mobility, stability, and confidence in movement.
Dr. Alexander Jimenez, DC, APRN, FNP-BC, CCST, CFMP, IFMCP, ATN, has described auto accident injuries through a layered clinical model.
His clinical observations emphasize that a collision may create several problems at the same time.
A patient may experience damaged tissue along with:
From this viewpoint, treating the tissue without correcting the movement pattern may leave some of the forces that contributed to continued irritation.
Dr. Jimenez’s published discussions therefore emphasize combining appropriate regenerative options with chiropractic care, functional medicine, personal injury management, and progressive rehabilitation (Jimenez, 2026a, 2026b).
Clinical progress can also be followed through measurable findings such as:
These observations help clinicians determine whether a patient is actually becoming more functional rather than relying solely on how the patient feels on one particular day.
At Injury Medical Clinic PA in El Paso, Texas, the care model brings different areas of healthcare together.
Clinic materials for ChiropracticScientist.com identify Dr. Maria Guadalupe Cardenas, MD, as the Medical Director and Collaborative Physician. She is described as board-certified in internal medicine with more than 40 years of clinical experience.
Clinic materials list:
Maria Guadalupe Cardenas, MD
Board-Certified Internal Medicine Physician
Medical Director and Collaborative Physician
Texas MD License #J2933
Clinic-listed NPI #1164426749
Dr. Cardenas provides medical direction alongside Dr. Alex Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST, whose work includes chiropractic care, family nurse practitioner services, functional medicine, personal injury care, and rehabilitation.
This type of multidisciplinary structure allows the team to consider several parts of recovery together.
The team may address:
This becomes especially important when a person injured in an auto accident also has diabetes, cardiovascular disease, medications, metabolic concerns, or other medical conditions that may affect recovery.
Regenerative medicine should not operate separately from the patient’s overall health.
Before considering a procedure, clinicians may need to evaluate factors such as:
Medical oversight can help determine when additional testing, medication management, imaging, referral, or specialist care is needed.
It can also help identify patients who should not receive MFAT.
MFAT should never be presented as a cure for every musculoskeletal problem.
Some injuries require other forms of treatment.
Examples may include:
The U.S. Food and Drug Administration also advises consumers to be careful when evaluating regenerative medicine treatments marketed for orthopedic conditions. Patients should understand exactly what treatment is being offered, what evidence supports it, and how it is regulated (U.S. Food and Drug Administration, 2021).
Auto accident recovery often requires more than simply treating the place that hurts.
A complete plan may need to address several layers.
Regenerative medicine may support the environment around damaged tissue.
Chiropractic care may help restore more normal joint and spinal movement.
Exercise and rehabilitation help the brain, nerves, and muscles work together again.
Patients gradually rebuild the ability to walk, lift, drive, exercise, work, and perform normal activities.
Functional medicine strategies may address nutrition, sleep, metabolic health, physical activity, and other factors that influence the body’s ability to recover.
MFAT represents an interesting development in orthopedic regenerative medicine.
It uses a patient’s own adipose tissue and preserves a natural mixture of cells, structural tissue, and biological signaling substances that may influence the healing environment.
Current research is most supportive in areas such as knee osteoarthritis. Evidence for traumatic cartilage, ligament, tendon, and other auto accident injuries continues to develop.
This means MFAT should be used thoughtfully.
For selected patients, the greatest opportunity may not come from viewing MFAT as a stand-alone injection.
Instead, consider it within a larger rehabilitation system.
Regenerative medicine addresses the tissue environment.
Scientific chiropractic care addresses biomechanics and movement.
Rehabilitation rebuilds strength and function.
Medical oversight helps manage safety and the patient’s overall health.
At the Chiropractic Scientist, this multidisciplinary approach reflects an important idea: successful injury recovery involves understanding both the science of damaged tissue and the science of human movement.
When those two areas work together, patients with complex auto injuries can follow a more complete pathway toward mobility, function, and long-term recovery.
Baria, M. R., Barker, T., Durgam, S., Pedroza, A., Flanigan, D., Jia, L., Kaeding, C., & Magnussen, R. (2024). Microfragmented adipose tissue is equivalent to platelet-rich plasma for knee osteoarthritis at 12 months posttreatment: A randomized controlled trial. Orthopaedic Journal of Sports Medicine, 12(3). https://doi.org/10.1177/23259671241233916
Fu, H., & Wang, C. (2025). Micro-fragmented adipose tissue—An innovative therapeutic approach: A narrative review. Medicine, 104(9), e41724. https://doi.org/10.1097/MD.0000000000041724
Hohmann, E., Keough, N., Frank, R. M., & Rodeo, S. A. (2025). Microfragmented adipose tissue has no advantage over platelet-rich plasma and bone marrow aspirate injections for symptomatic knee osteoarthritis: A systematic review and meta-analysis. The American Journal of Sports Medicine, 53(4), 988–998.
Jimenez, A. (2026a). When MFAT is recommended after injuries: Options. DrAlexJimenez.com.
Jimenez, A. (2026b). Can old car accident injuries heal with integrative care?. DrAlexJimenez.com.
Jimenez, A. (2026c). MFAT for personal injuries: When is it recommended?. ChiroMed.
Jimenez, A. (2026d). Micro-fragmented adipose tissue helps complex injuries heal. El Paso Back Clinic.
Jimenez, A. (n.d.). Dr. Alexander Jimenez professional profile. LinkedIn.
Ortho-Regen PDX. (n.d.). Microfragmented adipose tissue (MFAT). Ortho-Regen.
Richter, D. L., et al. (2025). Microfragmented adipose tissue injection reduced pain compared with a saline control among patients with symptomatic osteoarthritis of the knee during 1-year follow-up. Arthroscopy: The Journal of Arthroscopic & Related Surgery.
Sellers Sports Medicine. (n.d.). Micro-fragmented adipose tissue (MFAT): A breakthrough treatment for knee arthritis. Sellers Sports Medicine and Family Practice.
U.S. Food and Drug Administration. (2021). Important patient and consumer information about regenerative medicine therapies. U.S. Food and Drug Administration.
Yuan, C., et al. (2026). Micro-fragmented adipose tissue (MFAT) in orthopedic regenerative medicine: A narrative review of the biological basis and clinical evidence. International Journal of Molecular Sciences, 27(14), 6185. https://doi.org/10.3390/ijms27146185
By Dr. Alexander Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST Read More
Does “Core Stability” Actually Prevent Back Pain? What the Evidence Says About Strength, Endurance, and… Read More
By: Dr. Alex Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST Read More
Exercise, Manual Care, Acupuncture, and Electroacupuncture: What Does the Evidence Say About Chronic Musculoskeletal Pain?… Read More
By: Dr. Alex Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST Read More
Is the Weekend Warrior Effect Real? What the Evidence Says About Sudden Activity Spikes and… Read More
Personal Injury, Trauma & Spine Rehab Specialists